溴隐亭治疗帕金森病
Bromocriptine in Parkinsonism.
作者信息
Pearce I, Pearce J M
出版信息
Br Med J. 1978 May 27;1(6124):1402-4. doi: 10.1136/bmj.1.6124.1402.
Abstract
A review of the effects of using bromocriptine in Parkinson's disease showed that it rarely helps patients not primarily improved by levodopa. Patients who show late failure with levadopa and whose response to treatment is declining are helped by combining the two drugs. High cost and severe psychosis are the main disadvantages of bromocriptine, and, although it is not recommended for patients who are doing well on levodopa, it is the best available drug for hospital use in patients who show late failure with levodopa.
摘要
一项关于使用溴隐亭治疗帕金森病效果的综述表明，对于那些主要未通过左旋多巴得到改善的患者，溴隐亭很少能起到帮助作用。对于左旋多巴出现晚期失效且对治疗反应逐渐下降的患者，联合使用这两种药物会有帮助。高成本和严重的精神病是溴隐亭的主要缺点，虽然不建议在左旋多巴治疗效果良好的患者中使用，但对于左旋多巴出现晚期失效的住院患者来说，它是目前可用的最佳药物。
相似文献
1
Bromocriptine in Parkinsonism.溴隐亭治疗帕金森病
Br Med J. 1978 May 27;1(6124):1402-4. doi: 10.1136/bmj.1.6124.1402.
2
Long-term treatment of parkinsonism with bromocriptine.
Lancet. 1978 Apr 8;1(8067):735-8. doi: 10.1016/s0140-6736(78)90856-5.
3
Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.溴隐亭与左旋多巴对帕金森病疗效的比较。
J Neurol Neurosurg Psychiatry. 1977 May;40(5):479-82. doi: 10.1136/jnnp.40.5.479.
4
Early combination therapy with bromocriptine and levodopa in Parkinson's disease.帕金森病中溴隐亭与左旋多巴的早期联合治疗。
Mov Disord. 1993 Jul;8(3):257-62. doi: 10.1002/mds.870080302.
5
Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease.高剂量溴隐亭对晚期帕金森病的长期治疗
Adv Neurol. 1987;45:539-42.
6
[Bromocriptine (Parlodel) in the treatment of Parkinson's disease. Summary of 7 years' experience].[溴隐亭（帕罗西汀）治疗帕金森病。7年经验总结]
Rev Med Liege. 1983 May 1;38(9):362-6.
7
Bromocriptine combined with levodopa in Parkinson's disease.溴隐亭与左旋多巴联合用于帕金森病
Eur Neurol. 1982;21(4):217-26. doi: 10.1159/000115484.
8
Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.溴隐亭的研究。第2部分。与左旋多巴治疗特发性帕金森病的双盲对照研究。
Neurology. 1976 Jun;26(6 PT 1):511-3. doi: 10.1212/wnl.26.6.511.
9
Primary combination therapy of early Parkinson's disease. A long-term comparison between the combined regimen bromocriptine/levodopa and levodopa monotherapy--first interim report.早期帕金森病的初始联合治疗。溴隐亭/左旋多巴联合方案与左旋多巴单药治疗的长期比较——首次中期报告。
Eur Neurol. 1992;32 Suppl 1:36-45. doi: 10.1159/000116868.
10
A comparative study of bromocriptine and levodopa in Parkinson's disease.溴隐亭与左旋多巴治疗帕金森病的对比研究。
Adv Biochem Psychopharmacol. 1980;23:271-5.
引用本文的文献
1
Bromocriptine concentration in saliva plasma after long-term treatment of patients with Parkinson's disease.帕金森病患者长期治疗后唾液和血浆中的溴隐亭浓度。
Eur J Clin Pharmacol. 1980 Aug;18(2):171-4. doi: 10.1007/BF00561586.
2
Gas-liquid chromatographic analysis of synovial fluid: volatile short-chain fatty acids in septic arthritis.滑液的气-液色谱分析：脓毒性关节炎中的挥发性短链脂肪酸
Ann Rheum Dis. 1983 Aug;42(4):362-7. doi: 10.1136/ard.42.4.362.
3
Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism.溴隐亭在动物和人体内的命运与处置。II：吸收、消除与代谢。
Eur J Drug Metab Pharmacokinet. 1983;8(1):51-62. doi: 10.1007/BF03189581.
4
Long-term experience with bromocriptine in advanced parkinsonism. Results after one year's treatment.溴隐亭治疗晚期帕金森病的长期经验。一年治疗后的结果。
J Neurol. 1982;228(4):249-58. doi: 10.1007/BF00313415.
5
Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.多巴胺激动剂辅助治疗帕金森病：溴隐亭和CU 32 - 085的开放试验
J Neurol. 1982;227(2):75-88. doi: 10.1007/BF00313773.
6
Low-dose bromocriptine in Parkinson's disease.低剂量溴隐亭治疗帕金森病
J Neurol Neurosurg Psychiatry. 1985 Apr;48(4):388-9. doi: 10.1136/jnnp.48.4.388.
7
Bromocriptine in Parkinson's disease: a double-blind study comparing "low-slow" and "high-fast" introductory dosage regimens in de novo patients. UK Bromocriptine Research Group.溴隐亭治疗帕金森病：一项针对初发患者比较“低-慢”和“高-快”初始剂量方案的双盲研究。英国溴隐亭研究小组。
J Neurol Neurosurg Psychiatry. 1989 Jan;52(1):77-82. doi: 10.1136/jnnp.52.1.77.
8
Pharmacokinetics of bromocriptine during continuous oral treatment of Parkinson's disease.帕金森病持续口服治疗期间溴隐亭的药代动力学
Eur J Clin Pharmacol. 1979 May 21;15(4):275-80. doi: 10.1007/BF00618517.
9
Dopamine agonists for negative symptoms in schizophrenia.用于治疗精神分裂症阴性症状的多巴胺激动剂。
Br J Clin Pharmacol. 1978 Dec;6(6):541-2. doi: 10.1111/j.1365-2125.1978.tb00882.x.
10
Aetiology and natural history of Parkinson's disease.帕金森病的病因及自然史。
Br Med J. 1978 Dec 16;2(6153):1664-6. doi: 10.1136/bmj.2.6153.1664-a.
本文引用的文献
1
Current concepts of Parkinsonism.帕金森病的当前概念。
Postgrad Med J. 1971 Dec;47(554):794-9. doi: 10.1136/pgmj.47.554.794.
2
Sustained levodopa therapy in parkinsonism.
Lancet. 1973 Oct 27;2(7835):929-31. doi: 10.1016/s0140-6736(73)92595-6.
3
Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.溴隐亭治疗帕金森病：长期治疗、剂量反应及与左旋多巴的比较。
J Neurol Neurosurg Psychiatry. 1976 Nov;39(11):1101-8. doi: 10.1136/jnnp.39.11.1101.
4
Treatment of parkinson's disease with bromocriptine.用溴隐亭治疗帕金森病。
N Engl J Med. 1976 Dec 16;295(25):1400-4. doi: 10.1056/NEJM197612162952504.
5
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.与阿扑吗啡、（+）-苯丙胺和左旋多巴相比，溴隐亭对中枢多巴胺受体的兴奋特性。
Br J Pharmacol. 1976 Jan;56(1):59-68. doi: 10.1111/j.1476-5381.1976.tb06959.x.
6
Bromocriptine.
Br J Hosp Med. 1977 Oct;18(4):336, 341-2.
7
On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients.
Neurology. 1975 Dec;25(12):1144-8. doi: 10.1212/wnl.25.12.1144.
8
Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial.在一项双盲、交叉试验中，比较CB 154（2-溴-α-麦角隐亭）与美多芭对帕金森震颤麻痹的疗效。
Acta Neurol Scand. 1976 Mar;53(3):189-200. doi: 10.1111/j.1600-0404.1976.tb04337.x.
9
Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.溴隐亭与左旋多巴对帕金森病疗效的比较。
J Neurol Neurosurg Psychiatry. 1977 May;40(5):479-82. doi: 10.1136/jnnp.40.5.479.
10
Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.溴隐亭与左旋多巴（含或不含卡比多巴）治疗帕金森病
Lancet. 1976 Aug 7;2(7980):272-5. doi: 10.1016/s0140-6736(76)90728-5.
Zotero 插件